Yonca Cagatay

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?

What are the main factors affecting the outcome of tocilizumab therapy in COVID-19-induced cytokine release syndrome?

Journal: European journal of rheumatology

Published: February 14, 2022

Subclinical biventricular systolic dysfunction in patients with systemic sclerosis.

Subclinical biventricular systolic dysfunction in patients with systemic sclerosis.

Journal: European journal of rheumatology

Published: September 17, 2018

A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.

A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.

Journal: Rheumatology international

Published: January 19, 2016

Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.

Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.

Journal: Journal of autoimmunity

Published: December 23, 2015

Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study.

Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study.

Journal: The Journal of rheumatology

Published: December 23, 2015

Association of TRPM Channel Gene Polymorphisms with Systemic Sclerosis.

Association of TRPM Channel Gene Polymorphisms with Systemic Sclerosis.

Journal: In vivo (Athens, Greece)

Published: November 08, 2015

The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosis.

The rate and significance of type 1/type 2 serum amyloid A protein gene polymorphisms in patients with ankylosing spondylitis and amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: August 25, 2015

Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.

Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.

Journal: Rheumatology international

Published: July 09, 2015

Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases.

Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases.

Journal: The Journal of rheumatology

Published: May 19, 2015

Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses.

Behçet disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses.

Journal: Medicine

Published: February 13, 2015

Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis.

Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis.

Journal: Rheumatology international

Published: December 20, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026